The promoters of both RNA polymerase II-and RNA polymerase 111-transcribed small nuclear RNA (snRNA) genes contain an essential and highly conserved proximal sequence element (PSE) approximately 55 bp upstream from the transcription start site. In addition, the upstream enhancers of all snRNA genes contain binding sites for octamer-binding transcription factors (Octs), and functional studies have indicated that the PSE and octamer elements work cooperatively. The present study has identified and characterized a novel transcription factor (designated PTF) which specifically binds to the PSE sequence of both RNA polymerase IIand RNA polymerase III-transcribed snRNA genes. PTF binding is markedly potentiated by Oct binding to an adjacent octamer site. This potentiation is effected by Oct-1, Oct-2, or the conserved POU domain of these factors. In agreement with these results and despite the independent binding of Octs to the promoter, PTF and Oct-i enhance transcription from the 7SK promoter in an interdependent manner. Moreover, the POU domain of Oct-1 is sufficient for significant in vitro activity in the presence of PTF. These results suggest that essential activation domains reside in PTF and that the potentiation of PTF binding by Octs plays a key role in the function of octamer-containing snRNA gene enhancers.
The small nuclear RNA (snRNA) genes can be divided into two classes on the basis of their structure and the type of RNA polymerase (II or III) responsible for their transcription. The promoters of the RNA polymerase TI-dependent snRNA genes (e.g., Ul to U5) contain both an upstream (-220) enhancer with a functional octamer element (often in association with sites for other factors) and an essential proximal (-55) sequence element (PSE) which fulfills the start site selection role played by the TATA box of many mRNA-encoding genes (for reviews, see references 5 and 45). The promoters of snRNA genes transcribed by RNA polymerase III (e.g., 7SK and U6) have the same enhancer-PSE structure but also contain a TATA box (at position -25) which is involved in both start site selection and determination of RNA polymerase specificity (29, 31, 32 ; for reviews, see references 22, 40, 44, and 60) . We and others have presented evidence that octamer-binding transcription factors (Octs) and other DNA-binding proteins active in RNA polymerase TI-dependent transcription also participate in transcription of the 7SK and U6 genes via the enhancer sequences (2, 17, 41) . We also have shown that in vitro activation of the 7SK promoter by purified Octs requires an intact PSE in addition to Oct-binding sites, suggesting that a factor(s) binding to the PSE interacts functionally with the Octs (41) . The PSE thus performs a critical role in the transcription of both classes of snRNA genes and, as the only common essential promoter element, may coordinate their activities. Thus far, however, no transcriptionally active proteins which interact with the PSEs of both class II and class III snRNA genes have been identified.. Using DNA probes with an Oct-binding site adjacent to the PSE, both mobility shift and DNase footprint assays have revealed a factor(s) which binds to the PSE of the 7SK gene in conjunction with Octs. This factor is designated PTF (for PSE transcription factor). We show that adjacent binding of either the ubiquitous Oct-1 or the lymphoid-enriched Oct-2 greatly potentiates binding of PTF to the PSE and results in a supershifted complex consisting of Oct, PTF, and DNA in the mobility shift assay. We have used the supershift assay to partially purify transcriptionally active PTF of probe, 0.05 to 2 ,ug of poly(dI-dC), 1 mM spermidine, 0.03% Nonidet P-40, 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.9), 50 mM KCl, 4% Ficoll, 0.5 mg of bovine serum albumin (BSA) per ml, 5% glycerol, and 0.5 to 1 mM dithiothreitol. Reactions were initiated by the addition of protein, and mixtures were incubated for 30 min at 30°C. The whole reaction mixture was electrophoresed on a 4% (37.5:1, acrylamide-bisacrylamide) polyacrylamide gel, with 0.5 x Tris-borate-EDTA and 0.03% Nonidet P-40, after a 30-min prerun. For DNase protection studies the Asp-718 sites of the O+P+ and O+P-probes were labelled either with [oa-32P]dGTP and the Klenow enzyme (noncoding strand) or with T4 polynucleotide kinase and [a1-32P]ATP after dephosphorylation (coding strand). Ten femtomoles of probe was used in a 20-,J reaction mixture containing 20 mM HEPES (pH 7.9), 50 mM KCl, 1 mM spermidine, 25 ,ug of poly(dI-dC), 2 mM MgCl2, 0.03% Nonidet P-40, and 0.1 mg of BSA per ml.
After incubation at 30°C for 30 min, DNase was added to 0.2 ,ug/ml and digestion was carried out for 30 s at 30°C. Double-stranded oligonucleotide competitors used in the mobility shift and footprint experiments had the following sequences: OCTA, 5'-TGCAACTCTTCACCTTATTTlGCA TAAGCGATTCTACTGC-3'; OCTA-, 5'-TGCAACTCTTC ACCTTCGGGTACGAAGCGATTCTACTGC-3'; SP1, 5'-GCCAAGCGACACCGGGGCGGGGCGGGGCGGGGC TGC-3'; 7SK PSE, 5'-AGCTCCAACTTGACCTAAGTGTA AAGTTGAGT-3'; Ul PSE, 5'-CTAAGTGACCGTGTGTG TAAAGATGAGGATCC-3'; and mouse U6 PSE, 5'-AAG GAAACTCACCCTAACTGTAAAGTAATTGTG-3'. The double-stranded probes used for the experiments shown in Fig. 2 were made by annealing primers to single-stranded oligonucleotides and extending them with the Klenow enzyme in the presence of [at-32P]dCTP.
Purification of PTF. The PTF employed for the experiments shown in Fig. 4 to 6 was prepared as follows. HeLa cell S100 extract (500 ml, 14 mg of protein per ml) prepared by the method of Dignam et al. (7) was precipitated with 40% ammonium sulfate. The precipitate was resuspended in BC buffer (20 mM HEPES [pH 7.9] , 20% [vol/vol] glycerol, 0.2 mM EDTA, 0.03% Nonidet P-40, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride), dialyzed to BC buffer-100 mM KCI, and loaded onto a 100-ml phosphocellulose (P11) column. After a BC buffer-300 mM KCl wash, most of the PTF eluted in the BC buffer-500 mM KCl step fraction, giving an approximately 10-fold purification and 2-to 4-fold concentration with respect to the input. The BC buffer-500 mM KCl eluate (180 mg of protein) was dialyzed to BC buffer-100 mM KCI and loaded onto a 20-ml DEAE-cellulose (48) , while the PTF-containing flowthrough fractions showed no reactivity. This Ku-free fraction was used for the functional studies in Fig. 5 and for PTF-Oct-1 DNA-binding studies cited below.
The PTF preparation used for experiments shown in Fig.  1 to 3 was prepared by chromatography of S100 extract from HeLa cells on P11 and DE-52 resins as described above, with the following changes: the ammonium sulfate precipitation step was omitted, PTF was recovered by this step elution in the first DE-52 chromatography step, and a second DE-52 chromatography step was carried out after the second P11 column step, with PTF elution by a linear gradient of 100 to 300 mM KCl. None of these fractions were checked for the presence of Ku antigen.
In vitro and in vivo transcription. 7SK maxigenes were constructed by site-directed mutagenesis to introduce the sequence 5'-CTAAGCTTGT-3' between positions +27 and +28 of the 7SK coding region. In vitro transcription with normal and factor-depleted extracts (see below) was carried out as described by Murphy et al. (41) (64) . The end-filled XbaIHindIII fragment isolated from pBS-octl+ was ligated with the end-filled BamHI site of PET-llb (63) . The resulting plasmid was introduced into BL21 (DE3) containing pLysS.
After induction with isopropyl-p-D-thiogalactopyranoside (IPTG), the extract was prepared by sonication in BC buffer-100 mM KCI containing 10% glycerol. After centrifugation at 10,000 x g for 15 min, the pellet was washed twice in the same buffer and dissolved in BC buffer-100 mM KCI containing 6 M guanidine-HCI. Soluble material was loaded onto a Superose 12 (25-ml) column (Pharmacia) equilibrated with BC buffer-100 mM KCI and eluted at a flow rate of 0.3 ml/min. Active fractions were dialyzed to BC buffer-50 mM KCI and loaded onto a Mono S (1-ml) column. The column was eluted with a linear gradient of 50 to 500 mM KCI. Oct-1 eluted at approximately 100 mM KCI and was stored at -70°C. To produce the POU domain of Oct-1 in bacteria, the Hindll-Avall fragment of pBS-oct-1+ was inserted into the XhoI site of the 6HisT-pET11 vector (14) . The resulting plasmid was introduced into BL21 (DE3) containing pLysS. After induction with IPTG, the extract was prepared by sonication in BC buffer-500 mM KCI. After centrifugation at 10,000 x g for 15 min, the supernatant was adjusted to 5 mM imidazole and loaded onto a Ni2+-nitrilotriacetic acid column (Qiagen). The column was then washed with 10 column volumes of BC buffer-500 mM KCI containing 20 mM imidazole before being eluted with BC buffer-500 mM KCI containing 100 mM imidazole. The Addition of 40 ng of a nonspecific competitor had no effect on either complex (lane 5). Therefore, the lower of the two PTF-dependent complexes seems to be specific, while the upper may contain both specific and nonspecific components, suggesting that PTF alone can bind weakly to the 7SK PSE. Fig. 2A) . We designed oligonucleotides with an octamer sequence upstream from these PSEs to determine the effect of adjacent binding of Octs on protein interactions with the PSE ( Fig.  2A ) (see references 5, 40 , and 47 for comparative diagrams of these different PSEs). Figure 2B shows the results of this investigation. As expected, all probes gave a single complex (0) with Oct-1 alone (lanes 3, 7, 11, 15, 19, and 23 24) there was a strong supershift band (PO) when PTF was present with Oct-1 (lanes 4, 8, 12, 16, and 20) . Thus, all of the mammalian PSEs tested are recognized by proteins in the PTF preparation, but Oct-1 binding to adjacent sequences greatly increases PTF binding to the PSEs. The failure to observe a supershift band with the Xenopus probe suggests that the human PSE-binding factors in this fraction do not bind efficiently to the amphibian PSE sequence. We cannot rule out the possibility that PTF would bind to this sequence under different assay conditions and/or in the context of the natural octamer and PSE in the amphibian gene. However, we have shown above that the relative positions of the two elements are quite flexible (Fig. 1B) .
In contrast to the results obtained with the other mammalian snRNA genes, incubation of the mouse U6 PSE with the PTF fraction resulted in the appearance of three relatively strong complexes (lane 18). This result suggests that PTF may have a higher affinity for the mouse U6 PSE than for the other PSEs. In an analysis of the specificity of these bands (Fig. 2C) , two (upper and lower) were inhibited by addition of 20 ng (100-fold molar excess) of an oligonucleotide containing the mouse U6 PSE (lane 9) but not by the same amount of an unrelated oligonucleotide (lane 7). The two specific complexes had the same mobility as the two bands marked with arrows in Fig. lB (lane 2) and probably represent complexes containing the same protein(s). Addition of 20 ng (100-fold molar excess) of the 7SK PSE oligonucleotide (lane 8) had much less effect on these two specific shifts than did addition of the U6 PSE, further indicating that PTF binds more strongly to the mouse U6 PSE. The mouse U6 PSE oligonucleotide also effectively competed for the Oct-PTF-DNA supershift complexes (PO) formed on all of the mammalian PSEs in the presence of both PTF and Oct-i (lanes 5, 12, 14, 16, and 18 ). An equivalent molar amount of oligonucleotide comprising either the Ul (lane 3) or the 7SK (lane 4) PSE did not compete as efficiently as the mouse U6 PSE (lane 5) for the Oct-PTF-DNA supershift complex formed on the 7SK PSE. Since the PSE-dependent supershift complexes observed on the reconstructed templates containing PSE sequences from both RNA polymerase IIand RNA polymerase III-transcribed snRNA genes have the same apparent specificity, we consider it likely that these complexes contain the same protein species and that we are not detecting RNA polymerase II-and RNA polymerase III-specific PSE-binding proteins in the PTF preparation.
The conserved POU domain of both Oct-1 and Oct-2 is sufficient to potentiate PTF binding. The ubiquitous Oct-1 and the B-cell-specific Oct-2 bind identically to the same octamer sequence and stimulate transcription of mRNA-encoding genes both in vitro and in vivo (9, 10, 38, 46, 54, 55, 66; reviewed in reference 51). These factors have been cloned (37, 53, 61, 64) and are closely related members of the POU family of transcription factors, which contain a DNA-binding region composed of a POU-specific domain and a POUhomeo domain (13; reviewed in reference 51). Since both Oct-1 and Oct-2 stimulate transcription of the 7SK gene in vitro (41), we tested various preparations of intact or truncated Oct-1 and Oct-2 to determine whether they were equally capable of Oct-mediated potentiation of PTF binding and which parts of the proteins were required. Figure 3 shows the results of testing natural Oct-1 purified from HeLa cells (Oct-ij, lanes 2 to 4), recombinant Oct-1 produced in bacteria (Oct-lB, lanes 5 to 7), recombinant Oct-2 produced by translation in rabbit reticulocyte lysate (Oct-2R, lanes (lanes 13 and 14) . With these experiments we have mapped the site of interaction of PTF on both strands of the 7SK PSE and have confirmed that the potentiation effect of Oct-1 can be observed in a DNase protection assay as well as in a mobility shift assay. A schematic summary of these data is shown in Fig. 4C .
We also investigated PTF binding to the wild-type 7SK promoter containing sequences extending to -243 (41). Recombinant Oct-1 gave the same extended footprint over the region from -90 to -243 (Fig. 4D, lanes 3 to 5) that was previously observed by using Oct-1 purified from HeLa cells (41) . Most Oct-1 and recombinant Oct-1 (data not shown), indicating that Ku antigen is not required for Oct-PTF interaction under the conditions used. PTF is active in transcription of the 7SK gene in vitro. To establish an assay for testing purified PTF, 7SK maxigenes containing octamer, PSE, and TATA elements (Fig. 1A) in their normal context were transcribed in HeLa cell nuclear extracts and the products were analyzed by quantitative primer extention. The RNA polymerase III-dependent adenovirus VAI gene was included as an internal control. In agreement with the results of previous studies with a Namalwa cell extract (41) , the template containing intact octamer and PSE elements was transcribed more efficiently (14-fold in this experiment) than templates with one or both of these elements mutated (Fig. SA, lane 1 versus lanes 2, 3, and 4) Transcription was then analyzed in extracts in which Oct-1 was selectively depleted with an Oct-specific DNA affinity matrix (Fig. 5B) . In this extract, the level of transcription was low and equivalent for the O+P+ (lane 1) and the O+P-(lane 2) templates, indicating that Oct-1 is necessary for transcriptional activation of the O+P+ template. Addition of increasing amounts of the Oct-1 POU domain, produced in bacteria, stimulated transcription of the O+P+ template to a maximum of fivefold (lanes 3 to 5), but this protein had little effect on transcription of O+P-(lane 6).
Addition of bacterially produced Oct-1 (Oct_1B) stimulated transcription of the O+P+ template to a maximum of 12-fold (lanes 7 to 9) but did not increase transcription of the O+P-template. These results show that bacterially produced Oct-1 is transcriptionally active in vitro and that the DNA-binding (POU) domain alone is sufficient to stimulate transcription, albeit to a lesser extent than the larger Oct-1 protein.
Transcription was then examined in an extract in which both Oct-1 and PTF were depleted with an OCTA-PSE-DNA affinity matrix (Fig. SC) Indeed, under these conditions the difference in transcription efficiency between the O+P+ and O+P-templates exceeded that seen in an undepleted nuclear extract (21-fold in this experiment compared to 14-fold in the extract analyzed in Fig. SA) , suggesting that PTF is limiting in the HeLa nuclear extract. We conclude from these results that PTF purified on the basis of its ability to bind to the 7SK PSE is transcriptionally active in vitro and that it functions in a cooperative (interdependent) fashion with purified Oct-i.
Since the templates used for the above-described studies were not identical to the wild-type 7SK gene, we compared their transcription efficiencies following transfection into HeLa cells (Fig. 5D) 2 3 4 5 6 7 8 9 10 2 to undetectable levels. These results indicate that the placement of octamer sites close to the TATA sequence does not simply overcome the need for a PSE sequence in vivo, and they suggest that the reconstructed O+P+ templates faithfully mimic at least some of the functional properties of the natural promoter.
DISCUSSION
The PSE is the one critical control element common to both RNA polymerase II-and RNA polymerase III-transcribed snRNA genes and has several potential roles: to coordinate the activities of these genes, to effect stimulation of the basal transcriptional machinery in response to enhancer elements, and, in a related role, to help select the basal transcription system (RNA polymerase II or RNA polymerase III) employed. Our documentation of a factor (PTF) that interacts conditionally with a variety of PSEs and exhibits transcriptional activity through at least one (7SK) is thus of considerable significance. Even if PTF is not directly involved in all of these processes, it will be required, along with other enhancer and general initiation factors, to elucidate the mechanisms involved. Waldschmidt et al. (67) recently reported the identification of a factor (PBP) which bound to the PSE of the mouse U6 gene. This factor was transcriptionally active in vitro and showed some character- istics similar to those of PTF. Both proteins bind readily to the PSE of the mouse U6 PSE in the absence of Oct-1, and both have similar chromatographic behavior, in that they bind to both phosphocellulose and DEAE resins. However, identity between these two proteins remains to be determined, especially since the PBP studies were restricted to an analysis of the mouse U6 gene and since it is possible that several distinct proteins bind to the PSE of snRNA genes. For example, Knuth et al. (19) have reported that the autoimmune antigen Ku (48) interacts with the PSE of the human Ul gene and is transcriptionally active in vitro (12) . We have determined that PTF and Ku are distinct proteins by chromatographic separation (see Results), and although Oct-1 and PTF interact cooperatively in the absence of Ku antigen, the involvement of this highly abundant nuclear protein in transcription of class III snRNA genes remains a possibility.
Functional interactions of PTF with the 7SK PSE. The demonstration of a functional interdependency between the 7SK PSE and an adjacent Oct-binding site in vitro prompted the utilization of an Oct-PSE mobility shift supershift assay which led to the detection and partial purification of a PSE-binding factor designated PTF. Although a partially purified PTF displayed weak binding to the PSE, binding was enhanced markedly by simultaneous interactions of either Oct-1 or Oct-2 with an adjacent octamer. Moreover, even though Octs readily bind to the octamer elements in the absence of PTF, preliminary studies have indicated that these interactions are markedly stabilized in the Oct-PTF-DNA complex. Both of these results indicate direct cooperative interactions between Octs and PTF. It was also observed that the conserved Oct-1 and Oct-2 POU domains involved in DNA recognition (reviewed in reference 51) suffice to enhance PTF binding, indicating primary interactions of PTF with conserved residues and/or structural features therein.
Functional studies in reconstituted transcription systems further showed that PTF is transcriptionally active but that stimulation of the basal promoter activity is dependent upon both PTF and either intact or truncated Oct-1. The inability of either factor alone to efficiently stimulate transcription has important implications for the mechanism of action of these factors (see below). It was also found that natural and recombinant Oct-1 and Oct-2 (39c) are equally active for PSE-dependent transcription by RNA polymerase III. These results confirm previous findings that Oct-1 and Oct-2, usually thought of as activators for RNA polymerase IIdependent promoters, also enhance in vitro transcription by RNA polymerase III-in this case by potentiating the binding of a second factor (PTF) to promoter sequences. However, it remains to be determined whether Oct-2 can stimulate transcription of class III snRNA genes in vivo. Possibly relevant is a recent report (66) (15) (16) (17) . Surprisingly, more recent work has provided direct evidence that TFIID, long known as a general factor for transcription of TATA-containing promoters by RNA polymerase 11 (42) , also is involved in transcription by RNA polymerases I and III (4, 30, 31, 57, 68 ; reviewed in reference 56). In the case of the human U6 promoter this involves TFIID interactions with the functional U6 TATA element (30, 22, 57) , and, paradoxically, the TATA box of vertebrate class III snRNA genes is a major determinant of RNA polymerase specificity (29, 32 (9, 46) , the constant level and DNA-binding activity of Oct-1 during induction (25) suggest the involvement of a second regulatory factor, which could either activate Oct-1 by covalent modification (50) or contribute an activation domain by stable interaction with Oct-1.
(ii) Herpesvirus immediate-early promoters. Induction by the viral activator VP16 involves distal control elements with Oct-i-binding sites and contiguous sequences for VP16 recognition (11, 20) . Although VP16 alone may bind weakly (20) , Oct-1 binding stimulates markedly the formation of a stable complex involving Oct-1, VP16, and another cellular factor(s) (11, 34, 43 (65, 66) .
(iii) Ig promoters. B-cell-specific activation is mediated via the octamer element, and the existence of lymphoid-specific Oct-2 has led to the presumption that it plays the major regulatory role for immunoglobulin (Ig) promoters (reviewed in reference 46). Consistent with this, purified Oct-2 was shown to activate Ig promoters in vitro (54) and ectopic expression of Oct-2 in HeLa cells activated artificial lymphoid-specific promoters and allowed mapping of N-and C-terminal activation domains (10, 38, 65) . However, transcriptional activation of natural B-cell-specific (Ig) promoters by ectopic Oct-2 in HeLa cells requires high concentrations of Oct-2 and is very inefficient compared with octamer-dependent expression in B cells (10) . More recently it has been shown that purified Oct-1 and Oct-2 have equal potential for octamer-dependent activation of Ig and H2B promoters in vitro (27, 46) , whereas efficient B-cell-specific transcription of Ig promoters requires a novel non-DNAbinding B-cell-specific accessory factor that works efficiently with either Oct-1 or Oct-2 (46) . This factor has been separated from Oct-2 and Oct-1, with which it interacts, and appears to be a more important determinant of tissuespecific Ig promoter function than is Oct-2 (30a). Thus, in these cases there is direct or indirect evidence that activation via Oct recognition sites involves not only interacting Octs but also equally important secondary factors whose interactions depend both on Oct binding and, in some cases, on additional DNA sequence elements. In light of these results, the relationship found for Octs and PTF on the snRNA genes is not surprising. However, this does provide the first clear demonstration of Octs interacting with cell-encoded proteins other than themselves (see below).
Protein-protein interactions involving POU-domain factors is not uncommon (reviewed in reference 51). The best-studied case is the heterologous Oct-i-VP16 interaction (see above), which has features in common with the Oct-PTF interactions. These include recruitment of an essential secondary factor into a promoter complex with the Oct and the direct recognition of DNA sequences by the secondary factor (see above). However, in the case of the Oct-PTF interaction, the two binding sites are clearly separable, whereas the VP16-Oct-1 complex forms directly over the target TAATGARAT. Furthermore, PTF binding is potentiated equally well by the Oct-1 and Oct-2 POU domains, implicating conserved residues in the interaction. In contrast, Oct-2 is remarkably inefficient relative to Oct-1 in promoting the binding of VP16 (9) , and the basis for this difference has been mapped to a few nonconserved residues in the Oct-1 POU-homeo domain (62) that is otherwise sufficient for complex formation (20) . Possibly relevant to this and in agreement with past observations that Oct-1 and Oct-2 are both proficient in 7SK promoter activation in vitro (41), Yang et al. (69) have reported that a hybrid Oct-2 protein can activate transcription from the U2 promoter by RNA polymerase II and that the POU-homeo domain (replaced with the GAL4 DNA-binding domain) is not required (but see also reference 66 discussed above). Thus, the regions of the POU domains involved in PTF versus VP16 interactions are clearly not identical and might be distinct. In view of the proposed mechanisms (see above), key questions for the future are the exact POU domain structural determinants for PTF binding and how regions outside the POU domains contribute to activation of snRNA promoters.
How does the 7SK gene enhancer work in vivo? We showed earlier that degenerate octamer sequences between -200 and the PSE could mediate Oct-dependent activation of 7SK promoter in vitro and that the region between -240 and -200 is not required (41) . It was further shown here that recombinant Oct-1 can bind to these degenerate octamer sequences and potentiate PTF binding to the PSE (Fig. 4D) , which could account for the activation of transcription observed in vitro. However, in contrast to these results and in agreement with Kleinert and coworkers (17, 18) , we find that removal of the region of the 7SK gene between -240 and -200 results in the loss of enhancer function in vivo (39a). Interestingly, this region contains two degenerate octamer-binding sites (at -236 and -218) with a CACCC sequence between them (17, 18, 41). Kleinert et al. (17, 18) showed that the -236 octamerlike sequence of the 7SK promoter had no effect on enhancer activity, while mutation of the CACCC sequence severly impaired enhancer function. However, the possible involvement of octamer-binding sequences was not ruled out, since mutation of the 6/8 octamer-like sequence at position -218 was necessary to completely eliminate enhancer activity in these studies (17, 18) . We have shown that both purified (41) and recombinant (Fig. 4D ) Oct-1 can bind to this sequence, which is reminiscent of the functional 6/8 octamer-like sequence at position -219 of the human Ui gene (58) . In addition, the sequence at -218 of the 7SK gene corresponds closely to the consensus noted by Dahlberg and Lund (5) for human snRNA gene enhancers. It appears then that both the CACCC sequence and the adjacent 6/8 octamer are required for full enhancer activity, which is similar to the case of the U2 gene enhancer, in which an SP1 site just upstream of the consensus octamer is required but not sufficient for efficient expression of the gene (16, 69) . Thus, the 7SK gene may have the same general structure as the other mammalian snRNA genes, which have octamer or octamerlike sequences in the enhancer region located around -220, approximately 160 bp upstream from the PSE. Indeed, in agreement with our own published studies, Kleinert et al. (17) showed that a consensus octamer sequence placed at -230 could functionally replace the natural enhancer of the 7SK gene. We have also shown here that a single octamer placed upstream of the 7SK 
